Yeah, it's a good question. Right now, our goal is to get to between 40 and 50 QTCs this year by the end of 23. What we're learning and what we know about patients with both beta thalassemia and with sickle cell disease is that some patients are willing to travel, but some patients would prefer to get treated closer to their home. Our goal ultimately will be to bring our treatments to patients so that they don't have to travel very far for treatment. But we're not going to say what we're growing to beyond the 40 to 50 right now. It's fair to assume that we'll probably end up with higher than 50, but we're not commenting on how many at this time.

Mar 29, 2023 / receipt, needs a key / Tom, other | earnings call 2023-03-29 | transcript 4c93dc8c-310b-4023-95b2-95952cbe0fae | chars 33394-34047 | segment 34